Molecular Devices Announces the Appointment of Susan Murphy as President
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: PR Web
SAN JOSE, Calif. (PRWEB) June 04, 2019 Molecular Devices, a global leader in life science analytical technologies, today announced the appointment of Susan Murphy as the new President of Molecular Devices, replacing Greg Milosevich who has been appointed President of Beckman Coulter Life Sciences?owned by Molecular Devices' parent company, Danaher Corporation.Since joining Molecular Devices in a scientific engineering role, Ms. Murphy has held various positions of increasing responsibilities in the areas of sales and commercial leadership. Most recently, she served as Molecular Devices Vice President & General Manager of commercial operations in western markets, where she led sales and all aspects of global marketing.In her new role, Ms. Murphy will provide innovative microplate reader and imaging technologies to advance protein and cell biology research around the globe. She plans to maintain that successful model while continuing to expand into high growth biologics and bioinformat
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Curious about Danaher (DHR) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- Aseptic Sampling Market Size To Exceed US$ 1.72 Billion By 2034: Fact.MR Report [Yahoo! Finance]Yahoo! Finance
- deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer [Yahoo! Finance]Yahoo! Finance
- Danaher Co. (NYSE: DHR) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $280.00 price target on the stock.MarketBeat
DHR
Earnings
- 1/30/24 - Beat
DHR
Sec Filings
- 4/12/24 - Form PX14A6G
- 4/1/24 - Form S-3ASR
- 4/1/24 - Form 25-NSE
- DHR's page on the SEC website